Our History

Founded in 1997, with dual headquarters in Australia and Singapore, Novotech was established with a bold vision to drive innovation in drug development by transforming clinical trials.

 
2025

Novotech Welcomes New Investment from GIC, Temasek, and Existing Investor TPG to Accelerate Global Growth

2023

Novotech expands activities to the Europe with acquisition of Clinical CRO EastHORN.

2022

Novotech expands activities to the US with acquisitions of Clinical CRO NCGS and Drug Development Consulting CBR International.

2021

Novotech acquired shareholdings in ObvioHealth (DCT) and Prospection (Health analytics).

2020

Merger of Novotech Group and PPC Group to form Novotech Health Holdings.

2019

PPC Group acquired Biosuntek, one of South Korea’s largest domestic CROs.

2018

Novotech acquires CNS – CRO focused on early-stage clinical trials. PPC launches Acrostar SMO.

2017

TPG acquires controlling stake in Novotech and PPC.

2007

Novotech Group began its entry into the markets in Asia.

1997

Novotech Group founded with an initial focus on regulatory affairs. PPC Group founded and established its first bioanalytical laboratory.

 

Since its founding, Novotech has grown into a global leader while preserving its deep-rooted expertise in the Asia-Pacific region. As the biotech industry evolves—shaped by scientific advancements, regulatory shifts, investment trends, and market demands—Novotech evolves with it, continuing to expand capabilities, embrace new clinical research models, and support next-generation therapies.

By integrating emerging technologies, optimizing trial execution, and navigating complex regulatory landscapes, Novotech remains at the forefront of accelerating drug development and delivering innovative solutions for biotech partners worldwide.
 

Our Name

Why “Novotech?” Our name reflects who we are and what we do:

Novo means “new,” and in advanced therapeutics, it symbolizes breakthrough drug discoveries, novel therapies, and first-in-class treatments.

Name breakdown

Tech stands for technology—representing our ability to power clinical trials through cutting-edge technology, AI-driven insights, and real-time data.

Novotech is more than a name